PATENT CLAIM ANALYSIS

Application Number: 15932249
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-02
Patent Classification: ["424", "489000"]

Abstract:
Compositions, methods and systems are provided for pulmonary or nasal delivery of active agents via a metered dose inhaler. In one embodiment, the compositions include a suspension medium, active agent particles, and suspending particles, in which the active agent particles and suspending particles form a co-suspension within the suspension medium.

Claim (Index 61):
The pharmaceutical composition of  claim 55 , wherein the amount of formoterol in the pharmaceutical composition is between about 0.01 mg/mL and about 1 mg/mL.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 88.0
- Lexical Diversity: 1.54054
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12790605', '12790448', '13281726', '13692904', '13109884']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8566624167216428
- 35 USC 102 Novelty (BERT): 0.6022973117782073
- Combined Prediction Score: 0.8312259062272992
- Mean Citation Score: 579.80172
- Max Citation Score: 598.5851
- Similarity Product: 428.49089747992167

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test